deferoxamine has been researched along with Sickle Cell Trait in 3 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Sickle Cell Trait: The condition of being heterozygous for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amendola, G | 1 |
| Garvin, J | 1 |
| Piomelli, S | 1 |
| Pippard, MJ | 1 |
| Baker, DL | 1 |
| Manno, CS | 1 |
1 review available for deferoxamine and Sickle Cell Trait
| Article | Year |
|---|---|
Iron overload and iron chelation therapy in thalassaemia and sickle cell haemoglobinopathies.
Topics: Anemia, Sickle Cell; Ascorbic Acid; Deferoxamine; Drug Administration Schedule; Forecasting; Humans; | 1987 |
2 other studies available for deferoxamine and Sickle Cell Trait
| Article | Year |
|---|---|
Cystic fibrosis in a black child with hemoglobin S-D disease.
Topics: Black People; Child; Cystic Fibrosis; Deferoxamine; Female; Hemochromatosis; Hemoglobinopathies; Hem | 1990 |
Rapid excretion of gallium-67 isotope in an iron-overloaded patient receiving high-dose intravenous deferoxamine.
Topics: Adult; Cerebral Hemorrhage; Cerebral Ventricles; Deferoxamine; Drug Administration Schedule; Fever; | 1988 |